Cargando…

Establishment of a Bluetongue Virus Infection Model in Mice that Are Deficient in the Alpha/Beta Interferon Receptor

Bluetongue (BT) is a noncontagious, insect-transmitted disease of ruminants caused by the bluetongue virus (BTV). A laboratory animal model would greatly facilitate the studies of pathogenesis, immune response and vaccination against BTV. Herein, we show that adult mice deficient in type I IFN recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvo-Pinilla, Eva, Rodríguez-Calvo, Teresa, Anguita, Juan, Sevilla, Noemí, Ortego, Javier
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2663843/ https://www.ncbi.nlm.nih.gov/pubmed/19357779 http://dx.doi.org/10.1371/journal.pone.0005171

Ejemplares similares

Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus
por: Calvo-Pinilla, Eva, et al.
Publicado: (2012)

Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
por: Marín-Lopez, Alejandro, et al.
Publicado: (2019)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Viral Vector Vaccines against Bluetongue Virus
por: Jiménez-Cabello, Luis, et al.
Publicado: (2020)

Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire
por: Rojas, José-Manuel, et al.
Publicado: (2017)

Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge
por: Moreno, Sandra, et al.
Publicado: (2020)

A protective bivalent vaccine against Rift Valley fever and bluetongue
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2020)

Diagnosing bluetongue virus in domestic ruminants: current perspectives
por: Rojas, José M, et al.
Publicado: (2019)

The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2(1-180)) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge
por: Utrilla-Trigo, Sergio, et al.
Publicado: (2022)

A Novel Case of Homozygous Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency With Hemophagocytic Lymphohistiocytosis
por: Gothe, Florian, et al.
Publicado: (2020)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

The Interplay between Bluetongue Virus Infections and Adaptive Immunity
por: Rodríguez-Martín, Daniel, et al.
Publicado: (2021)

Interferons Alpha, Beta, and Omega
por: Meager, Anthony
Publicado: (1998)

Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors
Publicado: (1995)

Vaccination as a Strategy to Prevent Bluetongue Virus Vertical Transmission
por: Rojas, José M., et al.
Publicado: (2021)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
por: Calvo-Pinilla, Eva, et al.
Publicado: (2015)

Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives
por: Jiménez-Cabello, Luis, et al.
Publicado: (2023)

Inhibition of the IFN Response by Bluetongue Virus: The Story So Far
por: Rojas, José Manuel, et al.
Publicado: (2021)

A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19
por: Khanmohammadi, Shaghayegh, et al.
Publicado: (2021)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Induction and control of the type I interferon pathway by Bluetongue virus
por: Vitour, Damien, et al.
Publicado: (2014)

Agonist and antagonist effects of interferon alpha and beta on activation of human macrophages. Two classes of interferon gamma receptors and blockade of the high-affinity sites by interferon alpha or beta
Publicado: (1988)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

Inhibition of Orbivirus Replication by Aurintricarboxylic Acid
por: Alonso, Celia, et al.
Publicado: (2020)

Zika Virus Infection in the Ovary Induces a Continuously Elevated Progesterone Level and Compromises Conception in Interferon Alpha/Beta Receptor-Deficient Mice
por: Zhang, Yingying, et al.
Publicado: (2022)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
por: Wittling, Megen C., et al.
Publicado: (2021)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
por: Sainz, Bruno, et al.
Publicado: (2005)

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
por: Aksular, Mine, et al.
Publicado: (2018)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency
por: Van der Sluis, Renée M., et al.
Publicado: (2020)

Depletion of alpha/beta T cells by a monoclonal antibody against the alpha/beta T cell receptor suppresses established adjuvant arthritis, but not established collagen-induced arthritis in rats
Publicado: (1992)

Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice
por: Saminathan, Mani, et al.
Publicado: (2021)

Mutagenesis-Mediated Decrease of Pathogenicity as a Feature of the Mutant Spectrum of a Viral Population
por: Sanz-Ramos, Marta, et al.
Publicado: (2012)

Establishment of an Immunological Method for Detection of Bluetongue Virus by Fluorescence-Linked Immunosorbent Assay
por: Yin, Jiajia, et al.
Publicado: (2022)

Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses
por: Martín, Verónica, et al.
Publicado: (2015)

Bluetongue Virus NS4 Protein Is an Interferon Antagonist and a Determinant of Virus Virulence
por: Ratinier, Maxime, et al.
Publicado: (2016)

Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
por: Burke, Thomas P, et al.
Publicado: (2021)

Interferon Alpha Induces Establishment of Alphaherpesvirus Latency in Sensory Neurons In Vitro
por: De Regge, Nick, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_5fvch8cgel3e62v7nr7eles6ns